Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-29 @ 1:14 PM
Study NCT ID:
NCT01305135
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2011-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-25
First Submit QC Date:
None
Study First Post Date:
2011-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-06
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL